Drawing for LOVIWELL

USPTO serial 97847737

LOVIWELL

Reviewed by CopyMark Law Group

Reg. 7465504Status 700Registered
Filing date
Status date
Registration date
Aug 6, 2024
Examiner
KEELEY, ALISON REBECCA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LOVIWELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bin Li

Bin Li LAW OFFICES OF BIN LI730 N DIAMOND BAR BLVDDIAMOND BAR, CA 91765United States

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic testing kits containing sterile medical specimen collection tools consisting primarily of swabs for medical purposes and also containing pipettes, and lancets for medical use and collection cards for the collection of blood, urine, saliva, and feces for use in testing and for monitoring various medical conditions, and also including instructions and return shipping packagingACTIVEMar 10, 2023
009Direct-to-consumer test kits containing medical laboratory research and diagnostic instruments in the nature of scientific research collection devices consisting of wipes, swabs, pipettes, and lancets for the collection of blood, urine, saliva and feces for use in diagnostic testing for taking samples for review for various medical conditions for medical research purposes onlyACTIVEMar 10, 2023
010Direct-to-consumer test kits containing medical instruments in the nature of medical devices for obtaining body fluid samples for taking samples for review for various medical conditions; medical diagnostic testing kits containing sterile medical specimen collection tools primarily consisting of lancets, saliva collection tubes, and also containing swabs and collection cards for the collection of blood, urine, saliva, and feces for use in testing and for monitoring various medical conditions, and also including instructions and return shipping packagingACTIVEMar 10, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 6, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 21, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 1, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 16, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 2, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 2, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 2, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 2, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 2, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 2, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 26, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 25, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2023DOCKASSIGNED TO EXAMINER—
Nov 28, 2023AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Nov 28, 2023ALIEASSIGNED TO LIE—
Jun 22, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 11, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 23, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance